GLP-I (7-37)

Short description:


  • Product Name:GLP-I (7-37)
  • CAS non:106612-94-6
  • Molecular formula:C151h28n40o47
  • Molecular pondus:3355,71 g / mol
  • Sequence:H-eius-Ala-GLU-Gly-Thre-Phe-Threus-Ser-ASP-Val-Ser, Ser-Tyrs-Leu-GLU-GLY-GLN, Ala TRP-Leu-Val, Lys-Gly-Arg -Gly-O Acetate salis
  • Species:Alba pulveris
  • Application:A hormone quod promovet catabolism, propter diabetes II - non tamen est probatus applicationem
  • Package:Secundum mos est scriptor requisitis
  • Product Detail

    Product Tags

    Keywords

    • Humanum GLP-I (7-37)
    • maxime parabilis pretium
    • CAS # 106612-94-6

    Details

    • Proname: Humanum GLP, I (7-37)
    • Casno: 106612-94-6
    • Molecular formula: c151h28n40o47
    • Specie Alba pulveris
    • Application: 106612-94-6
    • Delivivivivivivivitudine: Promptus Shipment
    • Package: secundum elit scriptor requisitis
    • Portus: Shenzhen
    • ProductCapacity: II Kilogram / mensis
    • Puritas: XCVIII%
    • Storage: II ~ VIII ℃. TUBUR
    • Translationem: a aere
    • Limitnum: I Gram

    Excellentia

     

    Professional peptide manufacturer in Sina.
    Qualitas in GMP gradu
    Magna cum competitive pretium
    Nostrum products includit: Generic Bulla peptide Apis, COLOR peptide, Custom Peptides et VETERINARIUS Peptides.

     

    Details

    Molecular formula:

    C151h28n40o47

    Missam relativum Missam:

    3355,71 g / mol

    CAS, Number:

    106612-94-6 (rete)

    Long-term repono:

    -20 ± V ° C

    Synonyma:

    Glucagon, sicut peptide I (7-37)

    Sequence:

    H-eius-Ala-GLU-Gly-Thre-Phe-Threus-Ser-ASP-Val-Ser, Ser-Tyrs-Leu-GLU-GLY-GLN, Ala TRP-Leu-Val, Lys-Gly-Arg

    -Gly-O acetate salis

    Agri application:

    Diabete II - Non tamen est probatus applicationem

    Active substantia:

    GLP, I (7-37) est insulinotropic peptide generatae ex praecursor peptide Glp-I (1-37). Post ingestion a prandium,

    Et truncatum Bioactive Sequentia GLP, I (7-37) et GLP, I (7-36) Esse sunt secretus a Domino cellulis intestinorum

    Mucosae. Administration GLP, I (7-37) Acetate augilatione GLYCOSA adductus insulin secretio et eodem inhibits Gluca

    secretio et CARDIACUS exinanitio.

     

     

    Company Profile:

    Company Name: Shenzhen JMMed Technology Co., Ltd.
    Statutum Year: MMIX
    Capital: 89.5 decies RMB
    Main Product: Oxytocin Acetate, Vasopressin Acetate, Desminin Acetate, Terlipressin Acetate, Caspofungin Acetate, Micafungin Sodium, EPtifibatide Acetate, Bivalin, Liraglutide Acetate, Linaclotide aceteate, degarelix acetate, buserelin acetate, cetrorelix acetate, Goselin
    Acetate, Argirelentia Acetate, Metrixyl Acetate, frangeretur-VIII, .. ...
    Nobis contendunt continuanding innovations in novam peptide synthesis technology et processus optimization et nostra technica quadrigis habere super decennium ex experientia in peptide synthesis.jym has feliciter summitto multum
    De Anda peptide apis et formulavit products cum CFDA et in quadraginta patents probatus.
    Nostra peptide plant sita est in Nanjing, Jiangsu provinciae et posuit eum a facility of 30,000 quadratum metris in obsequio cum CGMP Guideline. Facultatem facilitatem est audited et inspici ab utroque domesticis et internationalis clients.
    Et sua optimum qualis, summa competitive pretium et fortis technica firmamentum, Jym non solum habet lucrata recognitiones pro sua products ex investigationis organizations et pharmaceutical industries, sed etiam facti sunt unus ex fidelissimis amet in Sinis,. Jym dicata est unum de mundo ducens peptide provisor in proximo futurum.

  • Previous:
  • Next:

  • Scribere nuntium hic mitte nobis